Halozyme Therapeutics
HALO
$91.28
Share price
-1.57%
Change (1 day)
67.65%
Change (1 year)
Categories
Halozyme Therapeutics (HALO) - Net assets
Net assets on the balance sheet as of December 2024 : C$0.52 Billion
According to Halozyme Therapeutics's latest financial reports the company has C$0.52 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Halozyme Therapeutics - Net assets on balance sheet (from 2002 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-12-31 | $C$0.52 B | 369.67% |
| 2023-12-31 | $C$0.11 B | -51.76% |
| 2022-12-31 | $C$0.23 B | -8.21% |
| 2021-12-31 | $C$0.25 B | 30.33% |
| 2020-12-31 | $C$0.19 B | 60.7% |
| 2019-12-31 | $C$0.11 B | -64.65% |
| 2018-12-31 | $C$0.33 B | 29.42% |
| 2017-12-31 | $C$0.26 B | -700.16% |
| 2016-12-31 | $-C$43.65 Million | -173.18% |
| 2015-12-31 | $C$59.64 M | 24.3% |
| 2014-12-31 | $C$47.98 M | -325.52% |
| 2013-12-31 | $-C$21.28 Million | -143.8% |
| 2012-12-31 | $C$48.58 M | 338.15% |
| 2011-12-31 | $C$11.08 M | -45.5% |
| 2010-12-31 | $C$20.34 M | 180.07% |
| 2009-12-31 | $C$7.26 M | -61.16% |
| 2008-12-31 | $C$18.7 M | -67.55% |
| 2007-12-31 | $C$57.62 M | 114.45% |
| 2006-12-31 | $C$26.87 M | 26.78% |
| 2005-12-31 | $C$21.19 M | 19.05% |
| 2004-12-31 | $C$17.8 M | 3571.96% |
| 2003-12-31 | $C$0.48 M | -180.89% |
| 2002-12-31 | $-C$0.6 Million | -1747.73% |
| 2001-12-31 | $C$0.03 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 | -C$0.12 Billion | -121.66% | 🇺🇸 USA |
 | C$20.41 B | 3,822.70% | 🇺🇸 USA |
 | C$10.04 B | 1,830.62% | 🇺🇸 USA |
 | C$126.57 B | 24,224.32% | 🇺🇸 USA |
 | C$115.88 B | 22,168.97% | 🇫🇷 France |
 | C$102.25 B | 19,549.77% | 🇺🇸 USA |